IND IND is the abbreviation of Investigational New Drug, which refers to the approval of clinical research of new drugs. The production of new drugs requires two administrative approvals, one is in the clinical research phase (IND application), and the other is the completion of the clinical research registration (NDA application). Medicilon is the firstRead more
Blog
By medicilon | Featured Stories | Comments are Closed | 29 June, 2021 |
By medicilon | Featured Stories | Comments are Closed | 5 January, 2021 |
On January 1, 2021, Gluetacs and Shanghai Medicilon signed a strategic cooperation agreement in Medicilon Chuansha Park and reached a long-term strategic cooperative relationship. Former Director of the Institute of Organic Chemistry of the Chinese Academy of Sciences, former Vice President of the Shanghai Institute for Advanced Study, former Director of the Institute of ImmunochemistryRead more
By medicilon | Medicilon Events | Comments are Closed | 10 February, 2020 |
In 2019, Medicilon has had an extraordinary year. The steadily developing Medicilon made a huge accumulation in 2019 and achieved a qualitative leap. Let us look back on the moments of glory and Extraordinary “2 0 1 9”. 2 – Double Happiness I Listed on Sci-Tech Innovation Board in Shanghai On Nov. 5th 2019, ShanghaiRead more